Overview

Hypertonic Saline Injection For Urinary Incontinence

Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
0
Participant gender:
Female
Summary
The investigators aimed to evaluate the effectiveness and safety of periurethral hypertonic saline (10% NaCl) injection for the treatment of stress urinary incontinence (SUI) and stress-predominant mixed urinary incontinence (MUI) in women.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Turgut Ozal University
Collaborator:
Inonu University
Criteria
Inclusion Criteria:

The patients who described Stress Urinary Incontinence or Mixed Urinary Incontinence, those
who had incontinence during the Valsalva maneuver, patients with positive Marshal-Marchetti
test, and those with post-void residual urine volume ≤100 mL were included in the study.

Exclusion Criteria:

Temporary urinary incontinence, delirium, urinary tract infection, urethritis, pure urge
incontinence, nocturnal enuresis, decreased bladder compliance and detrusor contraction in
the urodynamic study, leakage of urine with low bladder pressure, psychiatric conditions
(severe depression and anxiety), body mass index (BMI) >35 kg/m2, and using drugs that may
influence bladder storage or emptying